A UK biotech company has launched what it describes as a world‑first platform of lab‑grown human muscle designed to give drug ...
Altimmune said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass. Altimmune is one of several smaller biotech companies pushing to ...
The diabetes drug Mounjaro will be tested alongside an experimental treatment to study how to maintain muscle mass while losing weight, according to an announcement Thursday—after earlier studies ...
Morning Overview on MSN
GLP-1 pioneers test obesity drugs that work even without GLP-1 signaling
For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 ...
Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...
The U.S. drugmaker spent nearly $2 billion in 2023 to acquire Versanis Bio's bimagrumab, which prevents the activity of a protein called myostatin to help preserve muscle. Lilly is testing bimagrumab ...
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while ...
A study suggests that some people who take a popular weight-loss drug called semaglutide may lose more muscle than others, especially older adults and women. The research also shows that eating more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results